Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aparajita Dey

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Sub-Cellular Biochemistry|February 13, 2013
Cytochrome P450 2E1: its clinical aspects and a brief perspective on the current research scenarioAparajita Dey
Life Sciences|July 6, 2010
Hyperglycemia-induced mitochondrial alterations in liverAparajita Dey, Kavitha Swaminathan
Food & Function|June 14, 2013
The role of antioxidants and other agents in alleviating hyperglycemia mediated oxidative stress and injury in liverAparajita Dey, J Lakshmanan
Current Diabetes Reviews|May 16, 2009
Hyperglycemia induced changes in liver: in vivo and in vitro studiesAparajita Dey, Karthikeyan Chandrasekaran
Cell Biology and Toxicology|April 2, 2011
Cytochrome P450 2E1 and hyperglycemia-induced liver injuryAparajita Dey, S Mathan Kumar
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2006
Geldanamycin, an inhibitor of Hsp90, potentiates cytochrome P4502E1-mediated toxicity in HepG2 cellsAparajita Dey, Arthur I Cederbaum
Hepatology (Baltimore, Md.)|June 1, 2007
Induction of cytochrome P450 2E1 [corrected] promotes liver injury in ob/ob miceAparajita Dey, Arthur I Cederbaum
Hepatology (Baltimore, Md.)|February 1, 2006
Alcohol and oxidative liver injuryAparajita Dey, Arthur I Cederbaum
Archives of Biochemistry and Biophysics|March 27, 2007
Geldanamycin, an inhibitor of Hsp90 increases cytochrome P450 2E1 mediated toxicity in HepG2 cells through sustained activation of the p38MAPK pathwayAparajita Dey, Arthur I Cederbaum
Life Sciences|January 29, 2013
Inhibition of CYP2E1 leads to decreased malondialdehyde-acetaldehyde adduct formation in VL-17A cells under chronic alcohol exposureKavitha Swaminathan, Dahn L Clemens, Aparajita Dey
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Sub-Cellular Biochemistry|February 13, 2013
Cytochrome P450 2E1: its clinical aspects and a brief perspective on the current research scenarioAparajita Dey
Life Sciences|July 6, 2010
Hyperglycemia-induced mitochondrial alterations in liverAparajita Dey, Kavitha Swaminathan
Food & Function|June 14, 2013
The role of antioxidants and other agents in alleviating hyperglycemia mediated oxidative stress and injury in liverAparajita Dey, J Lakshmanan
Current Diabetes Reviews|May 16, 2009
Hyperglycemia induced changes in liver: in vivo and in vitro studiesAparajita Dey, Karthikeyan Chandrasekaran
Cell Biology and Toxicology|April 2, 2011
Cytochrome P450 2E1 and hyperglycemia-induced liver injuryAparajita Dey, S Mathan Kumar
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2006
Geldanamycin, an inhibitor of Hsp90, potentiates cytochrome P4502E1-mediated toxicity in HepG2 cellsAparajita Dey, Arthur I Cederbaum
Hepatology (Baltimore, Md.)|June 1, 2007
Induction of cytochrome P450 2E1 [corrected] promotes liver injury in ob/ob miceAparajita Dey, Arthur I Cederbaum
Hepatology (Baltimore, Md.)|February 1, 2006
Alcohol and oxidative liver injuryAparajita Dey, Arthur I Cederbaum
Archives of Biochemistry and Biophysics|March 27, 2007
Geldanamycin, an inhibitor of Hsp90 increases cytochrome P450 2E1 mediated toxicity in HepG2 cells through sustained activation of the p38MAPK pathwayAparajita Dey, Arthur I Cederbaum
Life Sciences|January 29, 2013
Inhibition of CYP2E1 leads to decreased malondialdehyde-acetaldehyde adduct formation in VL-17A cells under chronic alcohol exposureKavitha Swaminathan, Dahn L Clemens, Aparajita Dey
Pageof 3